Home/Liferna Biotech/Kiyoshi Tachikawa, PhD

KT

Kiyoshi Tachikawa, PhD

CSO, Board Observer & Founder

Liferna Biotech

Therapeutic Areas

Autoimmune Diseases Fibrotic Diseases

Liferna Biotech Pipeline

Drug	Indication	Phase
Undisclosed RNA Therapeutic Program(s)	Systemic Sclerosis (SSc) / Autoimmune & Fibrotic Diseases	Pre-clinical

Leadership Team at Liferna Biotech

Dushyant Varshney, PhD

Chairman, CEO & Founder

Wendy D. Taylor, MSc

COO, Board Member & Founder

KC Kummerfeld, CPA

CFO, Board Member & Founder

Dinesh Khanna, MD, M.Sc.

View full Liferna Biotech profile